A Case Study on the Fiocruz and IBMP Partnership: Strengthening Biotechnology and Public Health in Brazil

Partnerships between public and private organizations are essential for advancing health innovation and improving national production capacity for medical solutions. This case study explores the long-term collaboration between Fiocruz and the Institute of Molecular Biology of Paran? (IBMP), which has played a pivotal role in enhancing Brazil's capacity to produce diagnostic kits and biotechnological products for the Unified Health System (Sistema ?nico de Sa?de ? SUS) Using qualitative methods, including interviews with key stakeholders and analysis of institutional records from 1999 to 2024, the study maps the evolution of this partnership, highlighting its strategic planning, implementation, and impact. Findings reveal that the success of this partnership is rooted in a culture of open innovation, functional entrepreneurship, and alignment with public health policies. Lessons learned from this experience offer valuable insights for similar initiatives seeking to strengthen national health systems and promote technological independence. This project demonstrated that the partnership model benefits Brazilian public health and can be replicated in other regions of the country. Understanding this partnership model offers valuable lessons for other countries seeking to strengthen their national health innovation systems through collaborative strategies.